Chlamydia trachomatis and Neisseria gonorrhea (CT and GC) Nucleic Acid Amplification Test System

The Florida Department of Health is seeking competitive bids for a laboratory-based nucleic acid amplification test (NAAT) system for the diagnostic detection of Chlamydia trachomatis and Neisseria gonorrhea (CT and GC) through an Invitation to Bid (ITB). The purpose of this procurement is to obtain a NAAT system to serve the Department of Health statewide, with a specific focus on the jurisdictions of Leon County and the city of Tallahassee. The ITB outlines detailed requirements for the NAAT system, including equipment specifications, testing capabilities, and performance standards. Prospective vendors must submit their bids by August 31, 2022. The contract award will be made in accordance with the basis of award criteria specified in the ITB, which may include factors such as pricing, technical capabilities, and past performance.

The ITB does not mention any set-aside designations or restrictions on the types of organizations that can respond. The addendum provided indicates that existing equipment may be utilized if the current vendor is awarded the contract, but new equipment would be required for a different vendor. The anticipated annual volume and percentage of testing for bacterial vaginosis is unknown, and vendors cannot gain additional points for providing additional value-added services. The ITB does not provide details on pricing terms, funding sources, or the potential award value or budget range for this procurement.